Cargando…

Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani

Development of a suitable vaccine against visceral leishmaniasis (VL), a fatal parasitic disease, is considered to be vital for maintaining the success of kala-azar control programs. The fact that Leishmania-infected individuals generate life-long immunity offers a viable proposition in this directi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joshi, Sumit, Yadav, Narendra Kumar, Rawat, Keerti, Kumar, Vikash, Ali, Rafat, Sahasrabuddhe, Amogh Anant, Siddiqi, Mohammad Imran, Haq, Wahajul, Sundar, Shyam, Dube, Anuradha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403406/ https://www.ncbi.nlm.nih.gov/pubmed/30873164 http://dx.doi.org/10.3389/fimmu.2019.00288

Ejemplares similares

A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis
por: Ratnapriya, Sneha, et al.
Publicado: (2021)

Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani
por: Joshi, Sumit, et al.
Publicado: (2016)

Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis
por: Gupta, Reema, et al.
Publicado: (2014)

Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani
por: Das, Sanchita, et al.
Publicado: (2015)

Over-Expression of 60s Ribosomal L23a Is Associated with Cellular Proliferation in SAG Resistant Clinical Isolates of Leishmania donovani
por: Das, Sanchita, et al.
Publicado: (2013)

Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters
por: Baharia, Rajendra K., et al.
Publicado: (2014)

Correction: Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters
por: Baharia, Rajendra K., et al.
Publicado: (2021)

Th1 Stimulatory Proteins of Leishmania donovani: Comparative Cellular and Protective Responses of rTriose Phosphate Isomerase, rProtein Disulfide Isomerase and rElongation Factor-2 in Combination with rHSP70 against Visceral Leishmaniasis
por: Jaiswal, Anil Kumar, et al.
Publicado: (2014)

Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral Leishmaniasis
por: Kushawaha, Pramod K., et al.
Publicado: (2012)

Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis
por: Kushawaha, Pramod Kumar, et al.
Publicado: (2012)

Seasonal Variation in the Prevalence of Sand Flies Infected with Leishmania donovani
por: Tiwary, Puja, et al.
Publicado: (2013)

Correction: Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis
por: Baharia, Rajendra K, et al.
Publicado: (2015)

Leishmania donovani: Immunostimulatory Cellular Responses of Membrane and Soluble Protein Fractions of Splenic Amastigotes in Cured Patient and Hamsters
por: Kumari, Shraddha, et al.
Publicado: (2012)

Quantitative Proteome Analysis of Leishmania donovani under Spermidine Starvation
por: Singh, Shalini, et al.
Publicado: (2016)

Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches
por: Joshi, Sumit, et al.
Publicado: (2014)

Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival
por: Pandey, Rajeev Kumar, et al.
Publicado: (2016)

Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology
por: Forgber, Michael, et al.
Publicado: (2006)

Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis
por: Baharia, Rajendra K, et al.
Publicado: (2015)

Dual-target drugs against Leishmania donovani for potential novel therapeutics
por: Bora, Kushal, et al.
Publicado: (2023)

Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
por: Verma, Aditya, et al.
Publicado: (2017)

Latent Infection with Leishmania donovani in Highly Endemic Villages in Bihar, India
por: Hasker, Epco, et al.
Publicado: (2013)

LEISHMANIA DONOVANI IN THE PERIPHERAL BLOOD
por: Young, Charles W., et al.
Publicado: (1923)

Methionine aminopeptidase 2 is a key regulator of apoptotic like cell death in Leishmania donovani
por: Kumar, Ritesh, et al.
Publicado: (2017)

Correction: Latent Infection with Leishmania donovani in Highly Endemic Villages in Bihar, India
por: Hasker, Epco, et al.
Publicado: (2013)

In-silico design of an immunoinformatics based multi-epitope vaccine against Leishmania donovani
por: Saha, Subhadip, et al.
Publicado: (2022)

Role of Efflux Pumps and Intracellular Thiols in Natural Antimony Resistant Isolates of Leishmania donovani
por: Rai, Smita, et al.
Publicado: (2013)

Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal
por: Picado, Albert, et al.
Publicado: (2014)

The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response
por: Dikhit, Manas Ranjan, et al.
Publicado: (2018)

Leishmania actin binds and nicks kDNA as well as inhibits decatenation activity of type II topoisomerase
por: Kapoor, Prabodh, et al.
Publicado: (2010)

Proteomic analysis of the secretome of Leishmania donovani
por: Silverman, J Maxwell, et al.
Publicado: (2008)

Surface antigens of Leishmania donovani promastigotes
Publicado: (1983)

Vaccine Development Against Leishmania donovani
por: Das, Amrita, et al.
Publicado: (2012)

Leishmania donovani bodies in bone marrow
por: Ali, Natasha, et al.
Publicado: (2014)

Livestock and rodents within an endemic focus of Visceral Leishmaniasis are not reservoir hosts for Leishmania donovani
por: Kushwaha, Anurag Kumar, et al.
Publicado: (2022)

Comparative in-silico genome analysis of Leishmania (Leishmania) donovani: A step towards its species specificity
por: S., Satheesh Kumar, et al.
Publicado: (2014)

An orally effective dihydropyrimidone (DHPM) analogue induces apoptosis-like cell death in clinical isolates of Leishmania donovani overexpressing pteridine reductase 1
por: Singh, Neeloo, et al.
Publicado: (2009)

Interferon-Gamma Release Assay (Modified QuantiFERON) as a Potential Marker of Infection for Leishmania donovani, a Proof of Concept Study
por: Gidwani, Kamlesh, et al.
Publicado: (2011)

Central Asian Rodents as Model Animals for Leishmania major and Leishmania donovani Research
por: Vojtkova, Barbora, et al.
Publicado: (2020)

Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains
por: Nico, Dirlei, et al.
Publicado: (2014)

Biochemical and biophysical characterization of Leishmania donovani gamma-glutamylcysteine synthetase
por: Agnihotri, Pragati, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_49vrt0ctuv0881sc4fe1j1qbie